Edmund Dunn, Principal Accounting Officer at Monte Rosa Therapeutics, Inc. (GLUE), sold 50,864 shares at $18.10 ($920K) on 2026-02-27, disclosed to the SEC on 2026-03-02.
Open-market sale of $920k GLUE by Principal Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.10 | 25,164 | $455K | 49.5% |
| 2 | $18.10 | 25,164 | $456K | 49.5% |
| 3 | $17.50 | 536 | $9K | 1.0% |
| Total | $18.09 avg | 50,864 | $920K | 100% |
| Filing → |
| GLUE | SELL | 2025-06-04 | $9K | — | Filing → |
| GLUE | SELL | 2024-07-09 | $6K | — | Filing → |
| GLUE | SELL | 2024-06-05 | $5K | — | Filing → |